3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Lymphoma, Non-Hodgkin
16
Myelodysplastic Syndromes
15
Leukemia, Myeloid, Acute
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Hodgkin Disease
15
Lymphoma, Mantle-Cell
14
Multiple Myeloma
13
Waldenstrom Macroglobulinemia
12
Graft vs Host Disease
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma
11
Leukemia
11
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
10
Sarcoma
9
Myeloproliferative Disorders
9
Burkitt Lymphoma
9
Tuberous Sclerosis
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Primary Myelofibrosis
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms
6
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myelomonocytic, Chronic
6
Congenital Abnormalities
6
Breast Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphangioleiomyomatosis
5
Interventions
Nivolumab
11
Ipilimumab
6
linrodostat
4
relatlimab
3
Pemetrexed
2
tislelizumab
1
regorafenib
1
ralimetinib
1
p38 Mitogen-Activated Protein Kinases
1
mirdametinib
1
gedatolisib
1
figitumumab
1
efatutazone
1
abemaciclib
1
Vorinostat
1
Tetanus Toxoid
1
Tamoxifen
1
Sunitinib
1
Ranitidine
1
Midazolam
1
LY2603618
1
LY2584702
1
Irinotecan
1
Gemcitabine
1
Fulvestrant
1
Dasatinib
1
Cyclophosphamide
1
Crizotinib
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Cancer
×
Sirolimus
×
Clear all
No trials found.